Stock DRMA DERMATA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Dermata Therapeutics, Inc.

Equities

DRMA

US2498453065

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-04-26 EDT 		5-day change 1st Jan Change
0.3427 USD +0.76% Intraday chart for Dermata Therapeutics, Inc. +6.73% -43.82%
03-21 Dermata Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
01-05 Wall Street Set to Open Lower as Monthly Jobs Data Much Stronger Than Expected MT

Chart calendar Dermata Therapeutics, Inc.

70.gZVYhHYziN59nlR-FTa6Qx-y9wumwXtBfCC6cTE8_Ls.-fMh5w5avIwW0R4MZXH-B3Dhu3jehhkuBWzVG1dtmez39m7pPnnNmRbuAQ~ccc3c8950e596947b3575d0005f70738

Upcoming events on Dermata Therapeutics, Inc.

2024-05-07 12:00 Annual General Meeting
2024-05-12 Q1 2024 Earnings Release (Projected)
2024-09-22 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-30 Q4 2024 Earnings Release (Projected)

Past events on Dermata Therapeutics, Inc.

2024-04-03 15:55 Emerging Growth Conference
2024-03-21 16:05 Q4 2023 Earnings Release
2024-02-07 12:35 Emerging Growth Conference
2024-01-12 12:00 Extraordinary Shareholders Meeting
2023-11-09 16:05 Q3 2023 Earnings Release
2023-09-11 07:00 H.C. Wainwright Global Investment Conference
2023-08-10 16:15 Q2 2023 Earnings Release
2023-08-03 12:00 Annual General Meeting
2023-05-11 16:05 Q1 2023 Earnings Release
2023-02-21 16:05 FY 2022 Earnings Release
2023-02-07 Extraordinary Shareholders Meeting
2022-11-10 17:20 Q3 2022 Earnings Release
2022-09-12 07:00 H.C. Wainwright Global Investment Conference
2022-08-31 15:30 Gilmartin Group Emerging Growth Conference
2022-08-15 16:05 Interim 2022 Earnings Release
2022-07-11 12:00 Annual General Meeting
2022-05-16 16:05 Q1 2022 Earnings Release
2022-03-28 15:00 Maxim Group Virtual Growth Conference
2022-03-28 08:30 FY 2021 Earnings Release
2022-01-10 07:00 H.C. Wainwright BioConnect Conference

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-7,86
-8,32
5.55%		-9,67
-10,5
7.55%		-8,04
-8,75
8.11%
-12,7

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-7,90
-8,93
11.54%		-9,61
-10,4
7.97%		-7,79
-8,55
8.81%
-15,0

Net income
Million USD		Released
Forecast
Spread 		-10,5
-11,5
8.97%		-9,61
-10,4
7.97%		-7,79
-8,55
8.81%
-12,4

EPS
USD		Released
Forecast
Spread 		-38,9
-50,9
23.58%		-13,9
-14,4
3.33%		-2,67
-4,22
36.73%
-1,38

Announcement Date28/03/2221/02/2321/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-2,55
-3,01
15.3%		-2,79
-3,34
16.58%		-2,73
-3,01
9.28%		-2,45
-2,71
9.57%		-1,71
-2,50
31.59%		-2,28
-2,11
-8%		-1,73
-2,21
21.49%		-1,81
-2,02
10.21%		-2,22
-2,93
24.24%
-2,51


-2,92


-3,30


-4,01

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-2,55
-3,59
28.79%		-2,79
-3,34
16.58%		-2,73
-3,01
9.28%		-2,42
-2,71
10.37%		-1,67
-2,50
33.27%		-2,24
-2,11
-6.22%		-1,70
-2,21
22.89%		-1,72
-2,00
13.87%		-2,13
-2,89
26.11%
-4,09


-3,88


-3,93


-3,12

Net income
Million USD		Released
Forecast
Spread 		-2,55
-3,59
28.79%		-2,79
-3,34
16.58%		-2,73
-3,01
9.28%		-2,42
-2,71
10.37%		-1,67
-2,50
33.27%		-2,24
-2,11
-6.22%		-1,70
-2,21
22.89%		-1,72
-2,00
13.87%		-2,13
-2,89
26.11%
-2,40


-2,85


-3,20


-3,98

EPS
USD		Released
Forecast
Spread 		-13,0
-6,72
-92.86%		-5,28
-6,40
17.5%		-3,84
-5,12
25%		-3,20
-3,52
9.09%		-1,92
-3,20
40%		-2,27
-2,65
14.34%		-0,63
-0,92
31.52%		-0,54
-0,63
14.29%		-0,21
-0,78
73.08%
-0,36


-0,42


-0,27


-0,33

Announcement Date28/03/2216/05/2215/08/2210/11/2221/02/2311/05/2310/08/2309/11/2321/03/24----

Upcoming sector events for Dermata Therapeutics, Inc.

2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-30 16:05 EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
2024-05-01 07:00 NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release
More events

Past sector events for Dermata Therapeutics, Inc.

Today HITGEN INC.: Q1 2024 Earnings Release (Projected)
Today CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-25 REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-25 16:05 PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-25 06:30 SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. DRMA Stock
  4. Calendar Dermata Therapeutics, Inc.